Cross-reactivity of Fusarium spp. in the Aspergillus galactomannan enzyme-linked immunosorbent assay

Journal of Clinical Microbiology

Volumn 50, Issue 3, 2012, Pages 1051-1053

  Tortorano, Anna Maria ^a   Esposto, Maria Carmela ^a   Prigitano, Anna ^a   Grancini, Anna ^b   Ossi, Cristina ^c   Cavanna, Caterina ^d   Lo Cascio, Giuliana ^e  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^e UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; PIPERACILLIN;

ADULT; ARTICLE; ASPERGILLUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS GALACTIMANNAN; BRONCHUS SECRETION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; FEMALE; FUNGUS ISOLATION; FUSARIOSIS; FUSARIUM; HEMATOLOGIC DISEASE; HUMAN; HUMAN TISSUE; INVASIVE ASPERGILLOSIS; MALE; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SYSTEMIC MYCOSIS;

ADULT; ASPERGILLOSIS; ASPERGILLUS; CHILD; CHILD, PRESCHOOL; CLINICAL LABORATORY TECHNIQUES; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FUSARIOSIS; FUSARIUM; HUMANS; MALE; MANNANS; MIDDLE AGED; YOUNG ADULT;

EID: 84857389358     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.05946-11     Document Type: Article

References (21)

1. Cummings JR, et al. 2007. Cross-reactivity of non-fungal species in the Aspergillus galactomannan enzyme immunoassay. Diagn. Microbiol. Infect. Dis. 59:113-115. (Pubitemid 47391183)
2. De Pauw B, et al. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 46:1813-1821.
3. Fekkar A, et al. 2009. Serum cross-reactivity with Aspergillus galactomannan and cryptococcal antigen during fatal disseminated Trichosporon dermatis infection. Clin. Infect. Dis. 49:1457-1458.
4. Giacchino M, et al. 2006. Aspergillus galactomannan enzyme-linked immunosorbent assay cross-reactivity caused by invasive Geotrichum capitatum. J. Clin. Microbiol. 44:3432-3434. (Pubitemid 44413798)
5. Guarro J. 2011. Lessons from animal studies for the treatment of invasive human infections due to uncommon fungi. J. Antimicrob. Chemother. 66:1447-1466.
6. Kappe R, Schulzeberge A. 1993. New cause for false-positive results with the Pastorex Aspergillus antigen latex agglutination-test. J. Clin. Microbiol. 31:2489 -2490.
7. Lortholary O, et al. 2010. International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole. Antimicrob. Agents Chemother. 54:4446-4450.
8. Morio F, et al. 2011. Invasive Myceliophthora thermophila infection mimicking invasive aspergillosis in a neutropenic patient: a new cause of crossreactivity with the Aspergillus galactomannan serum antigen assay. Med. Mycol. 49:883- 886.
9. Nucci M, Anaissie E. 2007. Fusarium infections in immunocompromised patients. Clin. Microbiol. Rev. 20:695-704. (Pubitemid 47623773)
10. O'Donnell K, Kistler HC, Cigelnik E, Ploetz RC. 1998. Multiple evolutionary origins of the fungus causing Panama disease of banana: concordant evidence from nuclear and mitochondrial gene genealogies. Proc. Nat. Acad. Sci. U. S. A. 95:2044 -2049.
11. O'Donnell K, et al. 2008. Molecular phylogenetic diversity, multilocus haplotype nomenclature, and in vitro antifungal resistance within the Fusarium solani species complex. J. Clin. Microbiol. 46:2477-2490.
12. O'Donnell K, et al. 2010. Internet-accessible DNA sequence database for identifying Fusaria from human and animal infections. J. Clin. Microbiol. 48:3708 -3718.
13. Pfeiffer CD, Fine JP, Safdar N. 2006. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin. Infect. Dis. 42:1417-1427.
14. Raad II, et al. 2006. Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin. Infect. Dis. 42:1398 -1403.
15. Spellberg B, et al. 2006. Comparison of antifungal treatments for murine fusariosis. J. Antimicrob. Chemother. 58:973-979.
16. Stynen D, et al. 1992. Rat monoclonal antibodies against Aspergillus galactomannan. Infect. Immun. 60:2237-2245.
17. Swanink CMA, Meis J, Rijs A, Donnelly JP, Verweij PE. 1997. Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan. J. Clin. Microbiol. 35:257-260. (Pubitemid 26422666)
18. Tanriover MD, Ascioglu S, Altun B, Uzun O. 2010. Galactomannan on the stage: prospective evaluation of the applicability in routine practice and surveillance. Mycoses 53:16-25.
19. Tortorano AM, et al. 2008. Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from northern Italy. Antimicrob. Agents Chemother. 52:2683-2685. (Pubitemid 351915710)
20. Wheat LJ, et al. 2007. Histoplasmosis-associated cross-reactivity in the BioRad Platelia Aspergillus enzyme immunoassay. Clin. Vaccine Immunol. 14:638-640.
21. Xavier MO, Pasqualotto AC, Cardoso ICE, Severo LC. 2009. Cross-reactivity of Paracoccidioides brasiliensis, Histoplasma capsulatum, and Cryptococcus species in the commercial Platelia Aspergillus Enzyme Immunoassay. Clin. Vaccine Immunol. 16:132-133.